戻る Agenda
Session 3 of Highlighted Presentations Followed by Q&A
Speaker(s)
COVID-19 Vaccines – Impact on Eudravigilance, Coding Guidelines and Transparency Aspects
Gilles Touraille, PHARMD, PHD
European Medicines Agency, Netherlands
Scientific Administrator
COVID-19 Vaccines – Impact on Eudravigilance, Coding Guidelines and Transparency Aspects
Rodrigo Postigo
European Medicines Agency, Netherlands
Signal Management Lead, Pharmacovigilance Office
COVID-19 Vaccines ICRSRS – A National Competent Authority (NCA) Perspective
Florence van Hunsel, PHARMD, PHD
Netherlands Pharmacovigilance Centre Lareb, Netherlands
Head Signal Detection